Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
05/09/1997 | WO1997016171A1 Membrane-fusible liposome with the use of recombinant sendai virus |
05/09/1997 | WO1997016166A1 Skin care preparation and method |
05/09/1997 | WO1997016078A1 Aromatic granulated material |
05/09/1997 | CA2236207A1 Improved process and composition for therapeutic cisplatin (cddp) |
05/09/1997 | CA2236175A1 New technology for wet granulation |
05/07/1997 | EP0771849A2 Polymer blends containing polyoxaesters |
05/07/1997 | EP0771832A2 Blends of absorbable polyoxaesters containing amines and/or amido groups |
05/07/1997 | EP0771566A1 Stabilization of colloidal systems by the formation of ionic lipid-polysaccharide complexes |
05/07/1997 | EP0771559A1 Cosmetic and pharmaceutical emulsions |
05/07/1997 | EP0771558A1 Cosmetic and pharmaceutical emulsions |
05/07/1997 | EP0771528A1 Bovine teat dip formulation |
05/07/1997 | EP0771339A1 Moisture barrier film coating composition, method, and coated form |
05/07/1997 | EP0771207A1 Use of magnesium hydroxide as a stool softener |
05/07/1997 | EP0771205A2 Novel clinical uses of polyene macrolides |
05/07/1997 | EP0771191A1 Immunological activity of rhamnolipids |
05/07/1997 | EP0771190A1 Lock and key micelles |
05/07/1997 | EP0771189A1 Inhalation composition |
05/07/1997 | EP0756479A4 Gentle anti-acne composition |
05/07/1997 | EP0703778B1 Methods and apparatus for making liposomes |
05/07/1997 | EP0686024B1 Thickening mixture based on guar gum or non-ionic cellulose and a cross-linked polymer, and cosmetic or dermatological hair- or skin-care composition containing said mixture |
05/07/1997 | EP0684973B1 Process for the preparation of a water-dispersible carotenoid preparation in powder form |
05/07/1997 | EP0670715B1 Oral delivery composition forming a microemulsion |
05/07/1997 | EP0662820B1 Compositions for treatmewnt of inflamed tissues |
05/07/1997 | EP0660676B1 Novel compositions |
05/07/1997 | EP0652774B1 Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether |
05/07/1997 | EP0599942B1 A method of making biocompatible capsules containing cells |
05/07/1997 | EP0587659B1 Pharmaceutical carrier |
05/07/1997 | EP0565522B1 Dried, rotary disc fatty acid microencapsulated bacteria |
05/07/1997 | EP0542969B1 Biodegradable particulate vector and method of synthesis |
05/07/1997 | EP0419563B1 Time release protein |
05/07/1997 | DE19541326A1 Wasserlösliche oder wasserdispergierbare Polyurethane mit endständigen Säuregruppen, ihre Herstellung und ihre Verwendung Water-soluble or water-dispersible polyurethanes having terminal acid groups, their preparation and their use |
05/07/1997 | DE19541260A1 Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut Therapeutic composition for transdermal administration of drugs through the skin |
05/07/1997 | DE19540446A1 Tablet or capsule for encouraging waking in persons having difficulty to wake up |
05/07/1997 | CN1149259A Stabilized homogenous suspensions AS computed tomography contrast agents |
05/07/1997 | CN1148986A New skin preparation composition |
05/07/1997 | CN1148984A Process for preparing pharmaceutical formulation containing insulin analog |
05/07/1997 | CN1148977A Rescription of Yiganning capsule for hepatitis B and its process |
05/07/1997 | CN1148967A Ointment |
05/07/1997 | CN1148965A Paste for parotid gland and preparation thereof |
05/07/1997 | CN1148964A Tongniaoling for diuresis |
05/07/1997 | CN1148962A Prescription of oral liquid for regulating blood sugar and blood lipid and preparation thereof |
05/07/1997 | CN1148961A Pellet for generation of semen |
05/07/1997 | CN1148960A Preparation of capsule and instant powder of extracts of wood frog oil |
05/07/1997 | CN1148959A Oral liquid of growth factor of animal thymus |
05/07/1997 | CN1148957A Aqueously soluble powder preparation of taxinol and its preparing method |
05/07/1997 | CN1148956A Method of production of sustained-release preparation |
05/07/1997 | CA2189520A1 Blends of absorbable polyoxaesters containing amines and/or amido groups |
05/06/1997 | US5627233 Biocompatability |
05/06/1997 | US5627216 Medicinal ointment for hemorrhoid and skin care |
05/06/1997 | US5627212 Esters of L-carnitine and acyl L-carnitine with hydoxy acids for producing pharmcaeutical compositions for treating dermatoses |
05/06/1997 | US5627171 Synergistic antimetastasis agents |
05/06/1997 | US5627159 Enhancement of lipid cationic transfections in the presence of serum |
05/06/1997 | US5627153 Anti-fungal methods and materials |
05/06/1997 | US5626880 Infusion preparation |
05/06/1997 | US5626879 Terfenadine oral granules |
05/06/1997 | US5626878 Reduction of electrostatic forces between magnesium trisilicate adsorbates |
05/06/1997 | US5626877 Polymer-based drug delivery system |
05/06/1997 | US5626876 Floating system for oral therapy |
05/06/1997 | US5626875 Stabilized galenic formulations comprising an acid labile benzimidazole compound and its preparation |
05/06/1997 | US5626874 Time release tablets with cores of active compounds and barrier layers with gels or polymers |
05/06/1997 | US5626873 Emulsions |
05/06/1997 | US5626871 Receptacles with cellulose and starch powders for allergies, asthma, bronchitis or lung diseases |
05/06/1997 | US5626870 Accurately controlled particle size |
05/06/1997 | US5626869 Pharmaceutical composition containing a defined lipid system |
05/06/1997 | US5626868 Amphoteric and nonionic surfactants with lipid vesicles |
05/06/1997 | US5626867 Liposome for cytotoxic agents |
05/06/1997 | US5626866 Drug-containing adhesive composite transdermal delivery device |
05/06/1997 | US5626865 Enzyme-orthokeratology |
05/06/1997 | US5626864 Preparation of colloidal aqueous solutions of active substances of low solubility |
05/06/1997 | US5626863 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
05/06/1997 | US5626862 Drug delivery from polymer matrices by release from matrix by degradation of polymer |
05/06/1997 | US5626856 Cosmetic delivery vehicles and related compositions |
05/06/1997 | US5626838 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
05/06/1997 | US5626832 Iodinated contrast agent |
05/06/1997 | US5626751 Filter unit and high-pressure sizing apparatus |
05/06/1997 | US5626561 Implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein |
05/06/1997 | CA2044132C Transdermal acrylic multipolymer drug delivery system |
05/06/1997 | CA2032394C Multiple encapsulated sweetener delivery system and method of preparation |
05/06/1997 | CA2023867C Sorbitol coated comestible and method of preparation |
05/02/1997 | EP0770627A1 Composition and methods using nitroxides to avoid oxygen toxicity |
05/02/1997 | EP0770391A2 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in pharmaceutical compositions |
05/02/1997 | EP0770390A1 Nasally administrable compositions containing physiologically active peptides |
05/02/1997 | EP0770387A1 Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic |
05/02/1997 | EP0770386A1 Lanperisone formulation |
05/02/1997 | EP0770384A1 Solid, anhydrous, pharmaceutical compositions for vaginal use |
05/02/1997 | EP0770383A1 Ophthalmic cromolyn gel preparation |
05/02/1997 | EP0770382A1 Cosmetic and/or pharmaceutical emulsions |
05/02/1997 | EP0770381A1 Support and composition containing it together with a stabilised cosmetic or dermatologic agent |
05/02/1997 | EP0770140A1 Nucleic acid containing composition, preparation and uses of same |
05/02/1997 | EP0770053A1 Positive photoactive compounds based on 2,6-dinitrobenzyl groups |
05/02/1997 | EP0769997A1 Method and apparatus for forming compression dosage units within the product package |
05/02/1997 | EP0769996A1 Method and apparatus for retaining a formed compression dosage unit within a die cavity |
05/02/1997 | EP0769995A1 Method and apparatus for forming compression dosage units |
05/02/1997 | EP0769973A1 Intrapulmonary drug delivery within therapeutically relevant inspiratory flow/volume values |
05/02/1997 | EP0769965A1 Aqueous risperidone formulations |
05/02/1997 | EP0769961A1 Attenuation of wound healing processes |
05/02/1997 | EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
05/02/1997 | EP0769953A1 Pharmaceutical compositions comprising co-dried sucralfate gel and polyalcohol |
05/02/1997 | EP0769949A1 Hydromorphone therapy |
05/02/1997 | EP0769948A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |